JNJ-55375515

DRUG2 trials

Sponsors

Janssen Research & Development, LLC

Conditions

Healthy

Phase 1

Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-55375515 in Healthy Participants

CompletedNCT02623491

Janssen Research & Development, LLCHealthy

Start: 2015-11-30End: 2016-09-30Updated: 2016-12-06

A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-55375515 in Healthy Male Participants

CompletedNCT03405441

Janssen Research & Development, LLCHealthy

Start: 2018-01-02End: 2018-09-04Updated: 2025-04-27